Literature DB >> 2657250

Preliminary results on clinical and immunological effects of thymus hormone preparations in AIDS.

P Hermans1, N Clumeck.   

Abstract

The human immunodeficiency virus (HIV) is the newly recognized agent of the acquired immunodeficiency syndrome (AIDS). Global defects of the immune functions, including T- and B-cell immunity, macrophage functions and cytokine production, are commonly observed among patients with HIV infection. Many studies have shown thymus involvement and endocrine function impairments among these patients. Clinical trials with thymic compounds aiming at restoring the immune dysfunctions will be reviewed.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2657250     DOI： 10.1007/bf02985223

Source DB:  PubMed          Journal:  Med Oncol Tumor Pharmacother        ISSN： 0736-0118


  13 in total

1.  Thymostimulin treatment in AIDS-related complex.

Authors:  L Palmisano; T Chisesi; M Galli; F M Gritti; G Ielasi; A Lazzarin; I Mezzaroma; M Moroni; E Raise; A Vaglia
Journal:  Clin Immunol Immunopathol       Date:  1988-06

2.  Stimulation of cellular function by thymopentin (TP-5) in three AIDS patients.

Authors:  F Mascart-Lemone; K Huygen; N Clumeck; D Brenez; K Bolla; J Duchateau
Journal:  Lancet       Date:  1983-09-24       Impact factor: 79.321

3.  Low serum thymic hormone levels in patients with acquired immunodeficiency syndrome.

Authors:  M Dardenne; J F Bach; B Safai
Journal:  N Engl J Med       Date:  1983-07-07       Impact factor: 91.245

4.  In vitro effects of thymosin and lithium on lymphoproliferative responses of normal donors and HIV seropositive male homosexuals with AIDS-related complex.

Authors:  M B Sztein; G L Simon; D M Parenti; R Scheib; A L Goldstein; R Goodman; R DiGioia; H Paxton; A B Skotnicki; R S Schulof
Journal:  Clin Immunol Immunopathol       Date:  1987-07

5.  Thymopentin treatment in AIDS and pre-AIDS patients.

Authors:  N Clumeck; S Cran; P Van de Perre; F Mascart-Lemone; J Duchateau; K Bolla
Journal:  Surv Immunol Res       Date:  1985

6.  Some observations on various dose regimens of thymopentin treatment in rheumatoid arthritis.

Authors:  L Molin; F Schmid; K Bolla
Journal:  Surv Immunol Res       Date:  1985

7.  Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS).

Authors:  R C Gallo; P S Sarin; E P Gelmann; M Robert-Guroff; E Richardson; V S Kalyanaraman; D Mann; G D Sidhu; R E Stahl; S Zolla-Pazner; J Leibowitch; M Popovic
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

8.  A calf thymus acid lysate improves clinical symptoms and T-cell defects in the early stages of HIV infection: second report.

Authors:  G Valesini; V Barnaba; R Benvenuto; F Balsano; P Mazzanti; P Cazzola
Journal:  Eur J Cancer Clin Oncol       Date:  1987-12

9.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

Review 10.  Antiviral drugs other than zidovudine and immunomodulating therapies in human immunodeficiency virus infection. An overview.

Authors:  N Clumeck; P Hermans
Journal:  Am J Med       Date:  1988-08-29       Impact factor: 4.965
View more
  1 in total

1.  Weight gain, improvements in metabolic profiles and immunogenicity with insulin or sulphonylurea administration in AIDS.

Authors:  Udaya M Kabadi; Mary U Kabadi
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.